Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Funds support continued patient enrolment into the Ri-CoDIFy Phase 3 clinical trial program of ridinilazole for the treatment of Clostridium difficile infection; launch of Ridinilazole and Development of early-stage research projects using the Company’s Discuva Platform.
Lead Product(s): Ridinilazole
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Undisclosed
Deal Size: $50.0 million Upfront Cash: Undisclosed
Deal Type: Financing October 02, 2020
Details:
Quest will add the Enemeez and DocuSol brands of bowel care products, to its' portfolio of self-care products.
Lead Product(s): Docusate Potassium
Therapeutic Area: Gastroenterology Product Name: Enemeez
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Quest Products, LLC
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition June 24, 2020